Vetsys Pharmaceutical
Global Standard Formulations for Pet and Livestock Health
Leading the shift toward palatable and efficient drug delivery
The global pharmaceutical industry is witnessing a paradigm shift in veterinary medicine. Traditionally, administering medication to livestock and pets was a challenge due to poor palatability and stress during handling. Chewable tablets have emerged as the gold standard, combining therapeutic efficacy with ease of administration. As a premier China Chewable Tablets Exporter, we recognize that the global market for pet supplements and medicine is projected to grow significantly, driven by the "humanization" of pets and the industrialization of livestock farming.
From North America to Southeast Asia, the demand for highly bioavailable and palatable oral dosage forms is at an all-time high. Modern veterinary practices now prioritize stress-free treatment, making chewable formulations—which often mimic treats—the preferred choice for both veterinarians and pet owners worldwide.
Integrating AI and Biotechnology for Advanced Formulations
Utilizing molecular flavoring technology to mask the bitter taste of active ingredients like Amoxicillin or Doxycycline, ensuring 100% voluntary intake.
Combining traditional Chinese medicine extracts like Salvia and Astragalus with modern chewable bases for holistic animal wellness.
Leveraging AI to simulate drug release profiles, optimizing the 74% bioavailability found in our top-tier bolus products.
Focusing on sustainable raw materials and green manufacturing processes to minimize environmental footprint across the global supply chain.
A Leader in Animal Healthcare Since 2005
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Vetsys distinguishes itself by placing a strong emphasis on technological development. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands.
Quality is the cornerstone of our operations. We adhere to rigorous GMP standards, ensuring all products undergo extensive quality control checks before reaching the market. This focus maintains trust among our global partners.
We are actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets through partnerships and research collaborations.
State-of-the-art facilities for consistent pharmaceutical quality
The strategic advantage of Vetsys for global B2B procurement
As a prominent China Chewable Tablets Exporter, Vetsys offers the unique combination of large-scale production capacity and cost-effectiveness. Our 30 million RMB investment in infrastructure ensures that we can fulfill massive global orders—whether it’s for Amoxicillin Boluses or complex Vitamin B complexes—without compromising on delivery timelines or pharmaceutical purity.
Global enterprises require localized solutions. We provide OEM/ODM services for:
Our commitment to Experience, Expertise, Authoritativeness, and Trustworthiness is reflected in our GMP certifications. With an independent research institute and 5 specialized labs, we don’t just manufacture; we innovate. This R&D backbone allows us to provide technical dossiers and regulatory support for clients navigating international import requirements.
Top-rated exports for veterinary health and nutrition